Jiashan SDIC

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jun 5, 2020	Everest Medicines	$310.0M Series C	Hillhouse Capital, John Ho, Jiashan SDIC, RA Capital Management	Wei Fu, Cormorant Asset Management, Decheng Capital, GT Fund, HBM Healthcare Investments, Janus Henderson Investors, Octagon Capital, Pavilion Capital, Rock Springs Capital

Total Raised

N/A

Valuation

N/A